HomeCompareQTXB vs HDV

QTXB vs HDV: Dividend Comparison 2026

QTXB yields 400000.00% · HDV yields 2.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 QTXB wins by $5.011119029548644e+32M in total portfolio value
10 years
QTXB
QTXB
● Live price
400000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.011119029548644e+32M
Annual income
$500,865,583,351,836,840,000,000,000,000,000,000,000.00
Full QTXB calculator →
HDV
iShares Core High Dividend ETF
● Live price
2.92%
Share price
$135.39
Annual div
$3.96
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.3K
Annual income
$352.73
Full HDV calculator →

Portfolio growth — QTXB vs HDV

📍 QTXB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodQTXBHDV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, QTXB + HDV cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
QTXB pays
HDV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

QTXB
Annual income on $10K today (after 15% tax)
$34,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$425,735,745,849,061,300,000,000,000,000,000,000,000.00/yr
HDV
Annual income on $10K today (after 15% tax)
$248.52/yr
After 10yr DRIP, annual income (after tax)
$299.82/yr
At 15% tax rate, QTXB beats the other by $425,735,745,849,061,300,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of QTXB + HDV for your $10,000?

QTXB: 50%HDV: 50%
100% HDV50/50100% QTXB
Portfolio after 10yr
$2.505559514774322e+32M
Annual income
$250,432,791,675,918,420,000,000,000,000,000,000,000.00/yr
Blended yield
99.95%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

QTXB buys
0
HDV buys
0
No recent congressional trades found for QTXB or HDV in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricQTXBHDV
Forward yield400000.00%2.92%
Annual dividend / share$2.00$3.96
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$5.011119029548644e+32M$24.3K
Annual income after 10y$500,865,583,351,836,840,000,000,000,000,000,000,000.00$352.73
Total dividends collected$5.010957816668433e+32M$3.2K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: QTXB vs HDV ($10,000, DRIP)

YearQTXB PortfolioQTXB Income/yrHDV PortfolioHDV Income/yrGap
1← crossover$40,010,700$40,000,000.00$11,002$292.38+$40.00MQTXB
2$149,615,521,729$149,572,710,280.37$12,084$300.36+$149615.51MQTXB
3$522,880,052,725,200$522,719,964,116,949.25$13,250$308.02+$522880052.71MQTXB
4$1,707,862,989,289,045,000$1,707,303,507,632,628,700.00$14,506$315.35+$1707862989289.03MQTXB
5$5,213,509,402,845,684,000,000$5,211,681,989,447,144,000,000.00$15,858$322.35+$5213509402845684.00MQTXB
6$14,874,219,058,409,543,000,000,000$14,868,640,603,348,497,000,000,000.00$17,313$329.04+$14874219058409543680.00MQTXB
7$39,661,196,234,050,755,000,000,000,000$39,645,280,819,658,260,000,000,000,000.00$18,878$335.42+$3.966119623405075e+22MQTXB
8$98,838,436,350,327,300,000,000,000,000,000$98,795,998,870,356,880,000,000,000,000,000.00$20,560$341.49+$9.88384363503273e+25MQTXB
9$230,205,236,474,344,900,000,000,000,000,000,000$230,099,479,347,450,050,000,000,000,000,000,000.00$22,367$347.25+$2.302052364743449e+29MQTXB
10$501,111,902,954,864,400,000,000,000,000,000,000,000$500,865,583,351,836,840,000,000,000,000,000,000,000.00$24,307$352.73+$5.011119029548644e+32MQTXB

QTXB vs HDV: Complete Analysis 2026

QTXBStock

QuantRx Biomedical Corporation engages in the development and commercialization of patented miniform pads (PADs) and PAD based over-the-counter products in the United States. It is also developing genomic diagnostics for the laboratory market based on its lateral flow patents, including RapidSense technology, a one-step lateral flow test. The company's PAD products are used for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses, and other medical needs. Its products include InSync, a feminine hygienic interlabial pad; Unique miniform, a treated pad for the temporary relief of the itch and discomfort associated with hemorrhoids and minor vaginal infection, as well as an untreated pad for the daily protection of light urinary, vaginal, or anal leakage; and other treated miniform products. QuantRx Biomedical Corporation was incorporated in 1986 and is based in Tualatin, Oregon.

Full QTXB Calculator →

HDVETF

The iShares Core High Dividend ETF seeks to track the investment results of an index composed of relatively high dividend paying U.S. equities.

Full HDV Calculator →
📬

Get this QTXB vs HDV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

QTXB vs SCHDQTXB vs JEPIQTXB vs OQTXB vs KOQTXB vs MAINQTXB vs VYMQTXB vs DVYQTXB vs SPHD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.